breast cancer

(redirected from BRCA gene)
Also found in: Dictionary, Medical, Encyclopedia.
Related to BRCA gene: BRCA2 gene, Lynch syndrome
Graphic Thesaurus  🔍
Display ON
Animation ON
Legend
Synonym
Antonym
Related
  • noun

Words related to breast cancer

cancer of the breast

Related Words

References in periodicals archive ?
The National Institute for Health and Care Excellence (NICE) gaugedA that up to 700 women with the BRCA gene mutation need to beA treated forA the disease on a yearly basis.A Tablets can be taken twice a day after the first round of chemotherapyA itself, according to researchers.A
Since cancer cells with BRCA gene defects already have a poor repair system, targeting them using a PARP inhibitor worsens the damage and ultimately kills them.
"If you test positive for the BRCA gene you are monitored from an early age.
"My book entitled, 'Understanding BRCA' has just been released internationally and aims to improve the reader's understanding of the BRCA gene, the biology of genetics and what it means if an individual carries a harmful mutation.
PARP inhibitors are transforming the treatment of ovarian cancer, notably demonstrating marked clinical benefit in patients with and without germline mutations in a BRCA gene (gBRCA).
Another patient of mine, who carried the BRCA gene mutation, which increases the risk of breast and ovarian cancer, came to see me for IVF and pre-implantation genetic testing to avoid passing on the gene to her children.
Or, if they have a broken BRCA gene, they may want to have prophylactic surgery or add MRI scans to their mammogram screening program," he explained.
We have since found out she is a carrier of the BRCA gene.
However, if this type of specialized care is not available and you are simply looking for a quick assessment for one gene--for example, the BRCA gene that indicates a higher risk of breast cancer--there are kits available that enable you to have testing done at home.
This may be because of the discovery of a deleterious BRCA gene mutation, which places them at increased risk for ovarian cancer, but oophorectomy may also be a therapeutic option for their breast cancer: 60% of premenopausal breast cancers are hormone receptor-positive.
A total of 376 women with advanced triple-negative breast cancer took part in the trial, including 43 who had BRCA gene faults.
"The team at Newcastle University should be very proud of what they have achieved as Rubraca is offering hope to ovarian cancer patients with the BRCA gene mutation that they can live their life well.
Regulators in the United States have approved a drug for women with advanced breast cancer caused by BRCA gene mutations, which disproportionately affects Ashkenazi Jewish women.
Officially known as rucaparib, the drug offers a lifeline to women with advanced ovarian cancer, who have received two or more prior chemotherapies and whose tumours have a BRCA gene mutation.